Carmell Therapeutics has named Sebastian “Sebby” Borriello chief business officer. Borriello, who brings more than 30 years of experience to the role, joins from SK Life Science, where he served as chief commercial officer. While there, Borriello built out the drugmaker’s commercial organization and led the U.S. launch of its first product, Xcopri. 

Borriello spent the first 25 years of his career with Johnson & Johnson in various commercial leadership positions across the company’s wound management, biosurgery and aesthetics franchises.